Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

31%

4 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
7(63.6%)
Phase 4
4(36.4%)
11Total
N/A(7)
Phase 4(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT04014803Phase 4Recruiting

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Role: collaborator

NCT04769362Phase 4Recruiting

Long-term Beta-blocker Therapy After Acute Myocardial Infarction

Role: collaborator

NCT07241143Not ApplicableNot Yet Recruiting

Extra-Peritoneal Tunneling Versus Conventional Drain Fixation After Anterior or Low Anterior Resection

Role: collaborator

NCT06929897Not ApplicableNot Yet Recruiting

PVI Alone vs PVI With Posterior Wall Isolation for Pulse-Field Ablation in Persistent AF

Role: collaborator

NCT06889818Recruiting

Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)

Role: collaborator

NCT06864052Not ApplicableNot Yet Recruiting

The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation

Role: lead

NCT03993236Phase 4Completed

Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke

Role: collaborator

NCT05725187Enrolling By Invitation

Prospective Validation Study of AI-based Prediction Algorithm for the Prediction of Paroxysmal Atrial Fibrillation

Role: collaborator

NCT05865106Not ApplicableCompleted

The Efficacy and Feasibility of Smartphone-Based Speech Therapy for People with Post-Stroke Dysarthria

Role: lead

NCT05877950Not ApplicableNot Yet Recruiting

The Effectiveness of Smartphone-Based Speech Therapy for People with Post-Stroke Dysarthria

Role: lead

NCT06424548Not ApplicableNot Yet Recruiting

Comparison of the Improvement and Safety of the Ankle Brachial Arterial Pressure Index of Sarpogrelate and Clopidogrel in Stroke Patients With Decreased Ankle Brachial Arterial Pressure Index and Intermittent Claudication of Lower Limb Vascular Atherosclerosis.

Role: lead

NCT05146765Not ApplicableCompleted

Efficacy of a Digital Therapeutic for People With Dysarthria After Stroke

Role: lead

NCT05359224Phase 4Unknown

Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm

Role: collaborator

All 13 trials loaded